NORTHERN TRUST CORP - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 95 filers reported holding STOKE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.14 and the average weighting 1.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,045,570
-63.3%
265,373
-1.0%
0.00%
-100.0%
Q2 2023$2,850,274
+73.9%
268,135
+36.3%
0.00%
Q1 2023$1,639,185
-10.5%
196,781
-0.9%
0.00%
Q4 2022$1,832,303
-29.9%
198,516
-2.6%
0.00%
-100.0%
Q3 2022$2,615,000
-3.8%
203,715
-1.0%
0.00%0.0%
Q2 2022$2,719,000
-30.8%
205,801
+10.3%
0.00%0.0%
Q1 2022$3,929,000
-12.1%
186,635
+0.1%
0.00%0.0%
Q4 2021$4,472,000
-6.0%
186,384
-0.3%
0.00%0.0%
Q3 2021$4,756,000
-28.4%
186,942
-5.2%
0.00%0.0%
Q2 2021$6,639,000
-8.4%
197,252
+5.7%
0.00%0.0%
Q1 2021$7,250,000
-41.5%
186,660
-6.7%
0.00%
-50.0%
Q4 2020$12,384,000
+90.1%
199,970
+2.8%
0.00%
+100.0%
Q3 2020$6,516,000
+43.9%
194,557
+2.4%
0.00%0.0%
Q2 2020$4,527,000
-1.7%
189,960
-5.6%
0.00%0.0%
Q1 2020$4,607,000
+38.6%
201,137
+71.3%
0.00%0.0%
Q4 2019$3,325,000
+43.4%
117,404
+8.8%
0.00%0.0%
Q3 2019$2,319,000107,8960.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 16,786,713$562,187,00075.80%
RTW INVESTMENTS, LP 3,544,248$118,697,0002.86%
Cormorant Asset Management, LP 1,537,807$51,501,0001.98%
Redmile Group, LLC 2,549,506$85,383,0001.57%
Birchview Capital, LP 40,000$1,340,0000.45%
HighVista Strategies LLC 17,082$572,0000.42%
Perceptive Advisors 671,978$22,505,0000.33%
GILDER GAGNON HOWE & CO LLC 1,490,153$49,905,0000.31%
Artal Group S.A. 270,750$9,067,0000.22%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 323$11,0000.20%
View complete list of STOKE THERAPEUTICS INC shareholders